Dabigatran Etexilate vs Enoxaparin in Prevention of Venous Thromboembolism (VTE) Post Total Knee Replacement

NCT00152971 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2615

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthroplasty, Replacement, Knee
Thromboembolism

Interventions

DRUG: Dabigatran Dose 1 - day 2 to completion
DRUG: Dabigatran Dose 1 - day 1
DRUG: Dabigatran Dose 2 - day 2 to completion
DRUG: Dabigatran Dose 2 - day 1
DRUG: Enoxaparin

Sponsor

Boehringer Ingelheim